Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement

M.A. Dimopoulos; A. Palumbo; M. Attal; M. Beksac; F.E. Davies; M. Delforge; H. Einsele; R. Hajek; J.L. Harousseau; F.L. Da Costa; H. Ludwig; U.H. Mellqvist; G.J. Morgan; J.F. San-Miguel; S. Zweegman; P. Sonneveld

doi:10.1038/leu.2011.3

Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement

M.A. Dimopoulos
, A. Palumbo
, M. Attal
, M. Beksac
, F.E. Davies
, M. Delforge
, H. Einsele
, R. Hajek
, J.L. Harousseau
, F.L. Da Costa
, H. Ludwig
, U.H. Mellqvist
, G.J. Morgan
, J.F. San-Miguel
, S. Zweegman
, P. Sonneveld

Affiliatie VU

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	749-760
Journal	Leukemia
Volume	25
Issue number	5
DOIs	https://doi.org/10.1038/leu.2011.3
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/leu.2011.3

Cite this

Dimopoulos, M. A., Palumbo, A., Attal, M., Beksac, M., Davies, F. E., Delforge, M., Einsele, H., Hajek, R., Harousseau, J. L., Da Costa, F. L., Ludwig, H., Mellqvist, U. H., Morgan, G. J., San-Miguel, J. F., Zweegman, S., & Sonneveld, P. (2011). Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement. Leukemia, 25(5), 749-760. https://doi.org/10.1038/leu.2011.3

@article{5d6389f84d8f46e7ad7507217ee81610,

title = "Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement",

author = "M.A. Dimopoulos and A. Palumbo and M. Attal and M. Beksac and F.E. Davies and M. Delforge and H. Einsele and R. Hajek and J.L. Harousseau and \{Da Costa\}, F.L. and H. Ludwig and U.H. Mellqvist and G.J. Morgan and J.F. San-Miguel and S. Zweegman and P. Sonneveld",

year = "2011",

doi = "10.1038/leu.2011.3",

language = "Undefined/Unknown",

volume = "25",

pages = "749--760",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "5",

}

Dimopoulos, MA, Palumbo, A, Attal, M, Beksac, M, Davies, FE, Delforge, M, Einsele, H, Hajek, R, Harousseau, JL, Da Costa, FL, Ludwig, H, Mellqvist, UH, Morgan, GJ, San-Miguel, JF, Zweegman, S & Sonneveld, P 2011, 'Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement', Leukemia, vol. 25, no. 5, pp. 749-760. https://doi.org/10.1038/leu.2011.3

TY - JOUR

T1 - Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement

AU - Dimopoulos, M.A.

AU - Palumbo, A.

AU - Attal, M.

AU - Beksac, M.

AU - Davies, F.E.

AU - Delforge, M.

AU - Einsele, H.

AU - Hajek, R.

AU - Harousseau, J.L.

AU - Da Costa, F.L.

AU - Ludwig, H.

AU - Mellqvist, U.H.

AU - Morgan, G.J.

AU - San-Miguel, J.F.

AU - Zweegman, S.

AU - Sonneveld, P.

PY - 2011

Y1 - 2011

U2 - 10.1038/leu.2011.3

DO - 10.1038/leu.2011.3

M3 - Article

C2 - 21293488

SN - 0887-6924

VL - 25

SP - 749

EP - 760

JO - Leukemia

JF - Leukemia

IS - 5

ER -